US Strikes on Drug Boats Mount, Yet Cocaine Flow Remains Unabated

The Pentagon’s Southern Command confirmed on 30 May its latest lethal strike against a suspected drug smuggling vessel in the eastern Pacific, killing three people. The attack, carried out under Joint Task Force Southern Spear, is one of dozens in recent months that have collectively claimed more than 190 lives, marking the largest American military surge in Latin America in decades.

Yet nearly nine months into the offensive, a growing body of evidence suggests the campaign is failing to disrupt the cocaine trade. Epidemiologists, addiction scientists and public health specialists report that the drug is as readily available on US streets as before the strikes began. Analyses of street prices, fatal overdoses, drug purity and border seizures indicate no meaningful reduction in supply. Viewed from Washington, the operations target designated terrorist organisations; from academic and public health circles, however, the data tell a different story.

The financial costs are equally sobering. Brown University’s Costs of War project estimates the military operations have consumed $4.7 billion, encompassing surveillance aircraft, naval assets and special forces. Yet cocaine—the dominant drug trafficked from South America—continues to flow. Analysts note that traffickers have long adapted to enforcement pressure, shifting routes and methods, while demand in the world’s largest drug market remains undimmed.

This disconnect between tactical action and strategic outcome is fuelling a quiet but sharpening debate among policymakers and regional experts. Critics argue that a purely military approach cannot substitute for a comprehensive strategy addressing consumption, public health and the socioeconomic drivers of trafficking. As the body count rises and the cocaine trade endures, the long-term return on a multibillion-dollar investment built on kinetic force will come under increasing scrutiny.